Sign in
4

Changes in Ownership

Caribou Biosciences, Inc. Filed Acc 0001209191-21-070810

Options or other derivatives

  • Chief Scientific Officer acquired 147,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kanner Steven · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-12-20 Grant or award : show line 1 in the form Option to purchase Common Stock +147,000 147,000 D
Loading xslF345X03/doc4.xml…